NYQUIL SINUS OTC
Generic Name and Formulations:
Acetaminophen 325mg, doxylamine succinate 6.25mg, phenylephrine HCl 5mg; per liquiCap.
Procter & Gamble Pharmaceuticals
Indications for NYQUIL SINUS:
Sinus pain, congestion, rhinorrhea, sneezing, headache.
2 caps every 4 hours; max 6 doses/24 hours.
Analgesic + antihistamine + sympathomimetic.
During or within 14 days of MAOIs. Concomitant other acetaminophen products.
Hepatic dysfunction. Cardiovascular disease. Hypertension. GI or GU obstruction. Glaucoma. Thyroid disease. Diabetes. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. β-blockers increase pressor effects of sympathomimetics. Antagonizes antihypertensives. Increased CNS effects with other CNS depressants.
Drowsiness, nervousness, dizziness, insomnia, anticholinergic effects, excitability in children, hepatotoxicity (overdosage).
- Necessary Procedure Leads to Assault and Battery Charges
- Certain Antibiotics May Up Diabetes Risk
- FDA: Life-Threatening Interaction Possible Between Antivirals, Amiodarone
- Study: Abuse, Addiction, Poisoning Diagnoses Decrease with Reformulated Oxycontin
- Spironolactone for Hormonal Acne: Is Routine Potassium Monitoring Necessary?
- Public Health Emergency Declared in IN Following HIV Outbreak
- Study: Hospital Readmissions, Length of Stay Greater for C. diff Patients
- Does the Aviation Industry Need Better Mental Health Screening?
- National Strategy to Fight Superbugs Released by the White House
- Gene Mutation May Explain Severe Flu in Healthy Children